Penglei Wang

Zhengzhou, 450045, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Triptolide suppresses melanoma cell growth in vitro and in vivo through the Src-ERK signaling pathway.

Triptolide suppresses melanoma cell growth in vitro and in vivo through the Src-ERK signaling pathway.

Journal: Journal of Cancer
Published: July 12, 2024

RTN4IP1 Contributes to ESCC via Regulation of Amino Acid Transporters.

RTN4IP1 Contributes to ESCC via Regulation of Amino Acid Transporters.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 05, 2024

Targeting CRAF kinase in anti-cancer therapy: progress and opportunities.

Targeting CRAF kinase in anti-cancer therapy: progress and opportunities.

Journal: Molecular cancer
Published: August 31, 2023

Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma.

Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma.

Journal: Cancer research
Published: July 27, 2023

Multi-omics characterization of esophageal squamous cell carcinoma identifies molecular subtypes and therapeutic targets.

Multi-omics characterization of esophageal squamous cell carcinoma identifies molecular subtypes and therapeutic targets.

Journal: JCI insight
Published: May 02, 2023

Toosendanin targeting eEF2 impedes Topoisomerase I & II protein translation to suppress esophageal squamous cell carcinoma growth.

Toosendanin targeting eEF2 impedes Topoisomerase I & II protein translation to suppress esophageal squamous cell carcinoma growth.

Journal: Journal of experimental & clinical cancer research : CR
Published: January 12, 2023

Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1/2.

Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1/2.

Journal: Signal transduction and targeted therapy
Published: April 27, 2022

Periplogenin suppresses the growth of esophageal squamous cell carcinoma in vitro and in vivo by targeting STAT3.

Periplogenin suppresses the growth of esophageal squamous cell carcinoma in vitro and in vivo by targeting STAT3.

Journal: Oncogene
Published: October 12, 2020

Honokiol Inhibits Melanoma Growth by Targeting Keratin 18 in vitro and in vivo.

Honokiol Inhibits Melanoma Growth by Targeting Keratin 18 in vitro and in vivo.

Journal: Frontiers in cell and developmental biology
Published: September 07, 2020

PROTAC induced-BET protein degradation exhibits potent anti-osteosarcoma activity by triggering apoptosis.

PROTAC induced-BET protein degradation exhibits potent anti-osteosarcoma activity by triggering apoptosis.

Journal: Cell death & disease
Published: June 11, 2019

Targeted therapy of the AKT kinase inhibits esophageal squamous cell carcinoma growth in vitro and in vivo.

Targeted therapy of the AKT kinase inhibits esophageal squamous cell carcinoma growth in vitro and in vivo.

Journal: International journal of cancer
Published: October 11, 2018

Purpurogallin is a novel mitogen-activated protein kinase kinase 1/2 inhibitor that suppresses esophageal squamous cell carcinoma growth in vitro and in vivo.

Purpurogallin is a novel mitogen-activated protein kinase kinase 1/2 inhibitor that suppresses esophageal squamous cell carcinoma growth in vitro and in vivo.

Journal: Molecular carcinogenesis
Published: August 21, 2018
Showing 1-12 of 13

Last Updated: 09/26/2026